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HyperforinAdipocytes are insulin-sensitive cells that play a major role in energy homeostasis. Obesity is the primary dis-
ease of fat cells and a major risk factor for the development of Type 2 diabetes, cardiovascular disease, and
metabolic syndrome. The use of botanicals in the treatment of metabolic diseases is an emerging area of re-
search. In previous studies, we screened over 425 botanical extracts for their ability to modulate adipogenesis
and insulin sensitivity. We identiﬁed St. John's Wort (SJW) extracts as inhibitors of adipogenesis of 3T3-L1
cells and demonstrated that these extracts also inhibited insulin-sensitive glucose uptake in mature fat
cells. In these follow-up studies we have further characterized the effects of SJW on insulin action in both mu-
rine and human fat cells. We have shown that SJW also attenuates insulin-sensitive glucose uptake in human
adipocytes. Moreover, SJW inhibits IRS-1 tyrosine phosphorylation in both murine and human fat cells. Bo-
tanical extracts are complex mixtures. Many bioactive compounds have been identiﬁed in SJW, including
hypericin (HI) and hyperforin (HF). We have examined the ability of HI and HF, puriﬁed from SJW, to mod-
ulate adipocyte development and insulin action in mature adipocytes. Our novel studies indicate that the pro-
found effects of SJW on adipogenesis, IRS-1 activation, and insulin-stimulated glucose uptake are not
mediated by HI and/or HF. Nonetheless, we propose that extracts of SJW may contribute to adipocyte related
diseases by limiting differentiation of preadipocytes and signiﬁcantly inducing insulin resistance in mature
fat cells.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Herbal supplements, prepared from various plant parts (e.g.
ﬂowers, leaves, and roots) have been used as traditional medicines
to promote general good health and to treat disease for thousands
of years. In the U.S., there has been an increase in botanical supple-
ment use among consumers to treat many chronic disease states,
such as obesity, insulin resistance, and other risk factors of the meta-
bolic syndrome. According to the American Botanical Council, U.S.
consumers spent over $5 billion in 2009 on herbal supplements, up
17% over the previous 5 year period. Often the safety and efﬁcacy of
these herbal remedies has not been thoroughly investigated. In re-
sponse to these concerns, the federal government and national fund-
ing agencies have ampliﬁed their efforts to subject botanicals to
rigorous modern scientiﬁc research.
Adipocytes are lipid storing, insulin-sensitive cells that play a key
role in energy homeostasis. Obesity, the principal disease of adipo-
cytes, is a major risk factor of the metabolic syndrome, and signiﬁ-
cantly contributes to the development of Type 2 diabetes mellitusHF, hyperforin; T2DM, Type 2
-1 pY896, IRS-1 phosphorylated
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rights reserved.(T2DM), cardiovascular disease, and certain cancers. In the past, it
was thought that limiting adipose tissue development might be a
good way to combat obesity, and many researchers have investigated
anti-adipogenic agents as potential therapeutics for decreasing or
preventing obesity. However, the prevailing current hypothesis is
that disruption of adipocyte differentiation limits adipose tissue ex-
pansion and is linked to insulin resistance and the development of
T2DM [6,14]. Additionally, factors that interfere with the ability of ad-
ipocytes to store lipid, respond to insulin, or secrete adipokines may
promote the development of the metabolic syndrome [reviewed in
[3]]. Thus, we have hypothesized that the ability of a botanical extract
to modulate adipocyte development and/or function in a positive or
negative manner correlates with its ability to protect against or con-
tribute to metabolic syndrome and/or T2DM.
Previous screening efforts in our laboratory resulted in the identi-
ﬁcation of two extracts of St. John's Wort (Hypericum perforatum L)
that inhibited adipogenesis and induced insulin resistance in adipo-
cytes [1]. St. John's Wort (SJW) is used worldwide as a treatment
for depression and a variety of other conditions [4,11]. Since SJW is
readily available and consumed by millions of people, and both obesi-
ty and diabetes are world-wide epidemics, further understanding the
effects of SJW on adipocyte development and function is worthwhile.
Our previous investigations demonstrated that leaf and ﬂower ex-
tracts, but not root extracts, from SJW were capable of inhibiting ad-
ipocyte differentiation of 3T3-L1 cells. Moreover, these ﬂower and
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mature murine fat cells [1]. In this study, we observed that SJW can
modulate IRS-1 activation in both murine and human fat cells and
can also inhibit glucose uptake in human adipocytes. Moreover,
these studies examined the effects of hypericin (HI) and hyperforin
(HF), two well-known bioactive constituents of SJW that are associat-
ed with its antidepressant activity [5,17]. Overall, these studies iden-
tify IRS-1 as a target of SJW action on adipocytes, and this is the ﬁrst
study to show negative effects of this widely used botanical on
human fat cells.
2. Material and methods
2.1. Materials
Hypericin and amethanolic solution of hyperforin, both isolated from
St. John's Wort, and Dulbecco's modiﬁed Eagle's medium (DMEM) were
purchased from Sigma-Aldrich (St. Louis, MO). Bovine and fetal bovine
sera were purchased from HyClone (Thermo Scientiﬁc, Logan, UT). The
SJW ﬂower and root extracts were prepared at the Rutgers Botanical
Core facility as previously described [1]. For immunoblotting, polyclonal
STAT5A and IRS-1, and monoclonal PPARγ antibodies were purchased
from Santa Cruz Biotechnology. The polyclonal anti-aP2 and anti-
adiponectin antibodies were purchased from Abcam (Cambridge, MA)
and Thermo Scientiﬁc (Rockford, IL). Anti-phospho-IRS-1 (Tyr896),
which is polyclonal and highly speciﬁc for phospho-tyrosine 896 of the
mouse IRS-1, was purchased from Invitrogen (Carlsbad, CA). The BCA
and enhanced chemiluminescence kits were from Thermo Scientiﬁc.
Anti-rabbit and anti-mouse horseradish peroxidase-conjugated second-
ary antibodieswere purchased from Jackson ImmunoResearch Laborato-
ries. Mature human subcutaneous adipocytes were purchased in a 12-
well plate format from ZenBio. These human adipocytes were derived
from preadipocytes collected from the subcutaneous thigh region of
non-diabetic, females with a BMI of less than 25.
2.2. Cell culture
Murine 3T3-L1 preadipocytes were plated and grown to 2 days
post-conﬂuence in DMEM containing 10% bovine serum. Medium
was changed every 48–72 h. Cells were induced to differentiate by
changing the medium to DMEM containing a standard MDI induction
cocktail of 10% fetal bovine serum (FBS), 0.5 mM 3-isobutyl-1-meth-
ylxanthine, 1 μM dexamethasone, and 1.7 μM insulin. After 48 h, this
medium was replaced with DMEM supplemented with 10% FBS and
0.43 μM insulin. Each additional feeding occurred every 2–3 days in
DMEM supplemented with 10% FBS, and cells were maintained in
this medium until utilized for experimentation. Human adipocytes
were maintained in adipocyte maintenance media (Zenbio Cat #
AM-1) and used for experimentation within one week of arrival.
2.3. Whole cell extract preparation
Adipocyte monolayers were harvested in a non-denaturing buffer
containing 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EGTA, 1 mM
EDTA, 1% Triton X-100, 0.5% Igepal CA-630, 1 μM phenylmethylsulfo-
nyl ﬂuoride, 1 μM pepstatin, 50 trypsin inhibitory milliunits of aproti-
nin, 10 μM leupeptin, and 2 mM sodium vanadate. The samples were
either extracted on ice for 30 min or frozen. For analysis, the samples
were centrifuged at 13,000×g at 4 °C for 10 min. Supernatants con-
taining whole cell extracts were analyzed for protein content using
a BCA kit according to the manufacturer's instructions.
2.4. Gel electrophoresis and immunoblotting
Seventy-ﬁve to one-hundred-ﬁfty micrograms of protein from
whole cell extracts were separated on 7.5% or 15% SDS-polyacrylamidegels and transferred to nitrocellulose membrane in 25 mM Tris,
192 mM glycine, and 20% methanol. Following transfer, the membrane
was blocked in 4% milk and then immunoblotted. Results were visual-
ized with horseradish peroxidase-conjugated secondary antibodies
and enhanced chemiluminescence.
2.5. Oil Red O staining
An Oil Red O stock was prepared as previously described [16]. Cell
monolayers were aspirated and rinsed with PBS. Following incuba-
tion in a ﬁxative solution (10% formaldehyde in PBS) for 10–15 min,
the monolayers were rinsed under tap water. The remaining water
was aspirated, and the cells were incubated for 1 h in the working
Oil Red O solution (0.3% in isopropanol). Following incubation, the
stain was aspirated, the cells were rinsed under tap water, and then
they were examined by microscopy and scanned to produce the ﬁg-
ures in this manuscript.
2.6. Insulin-stimulated 2-[3H] deoxyglucose uptake assay
The assay of 2-[3H] deoxyglucose uptake was performed as previ-
ously described [22]. Prior to the assay, mature adipocytes were
serum deprived and pre-treated with SJW ﬂower extract, HI, or HF
for various times. Next, the cells were incubated in the presence or
absence of insulin (5 nM) for 7 min. Glucose uptake was initiated by
addition of 2-[3H] deoxyglucose at a concentration of 0.1 mM 2-
deoxyglucose in 1 mCi 2-[3H] deoxyglucose in Krebs–Ringer–Hepes
buffer and incubated for 3 min at room temperature. Glucose uptake
is reported as [3H] radioactivity and normalized to total protein con-
tent as determined by BCA analysis. Uptake measurements were per-
formed in triplicate under conditions where hexose uptake was
linear.
2.7. Statistics
Results were analyzed using the statistical software SAS® 9.3 (SAS
Institute, Inc., Cary, NC). The general linear models procedure was
employed to conduct an analysis of variance for glucose uptake and
to calculate least squares means and standard deviations. Statistical
signiﬁcance was declared for p-values≤0.05.
3. Results
3.1. Hypericin and hyperforin do not mediate the ability of SJW to inhibit
adipogenesis
We previously reported that St. John's Wort ﬂower and leaf, but
not root extracts, inhibited adipogenesis and induced insulin resis-
tance in adipocytes [1]. Hypericin and hyperforin are two key bioac-
tive constituents of SJW that have been reported to be responsible
for its antidepressant activity [5,17]. To determine if these constitu-
ents are capable of mediating the effects of the active SJW extracts
on adipocyte development and function, we examined the ability of
HI and HF that were puriﬁed from SJW to modulate adipocyte differ-
entiation and insulin sensitivity.
The following data were considered in the selection of appropriate
HI and HF concentrations for our experiments. The HF content within
SJW is typically ~3% but ranges from 2 to 5% [21]. The combined con-
tent of HI and pseudohypericin within SJW is typically ~0.3% but
ranges from 0.02 to 2.5% [20]. Based on the active concentrations of
SJW in our previous studies [1] and the typical percent composition
of HI and HF within SJW, the concentrations of active extract in
terms of HI and HF concentrations are equivalent to 0.02–0.3 μM HI
and 0.17–2.8 μM HF. Additionally, HI inhibits the action of protein ki-
nase C with an IC50 of 3.4 μM [23], and HF activates the pregnane X re-
ceptor with a binding constant of 27 nM [18]. Thus, we initially
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tion ranges of 0.05–6 μM HI and 0.01–0.47 μM HF (HF was commer-
cially available only as a 0.47 mM methanolic solution).
As shown in Fig. 1A, neither HI nor HF was capable of inhibiting
adipogenesis of 3T3-L1 cells as judged by Oil Red O staining, which
is indicative of lipid accumulation. The SJW ﬂower extract was used
as a positive control and completely blocked lipid accumulation,
while the root extract does not inhibit lipid accumulation and was
used as a negative control. HI doses of 3 μM and higher were toxic
and resulted in cell death as judged by detachment of the cell mono-
layer from the culture plate. Notably, there was no observable cell
death with HI and HF concentrations equivalent to 0.5 μM or lower
(data not shown).
Adipogenesis of 3T3-L1 cells was also assessed by examining the in-
duction of adipocytemarker proteins. As shown in Fig. 1B, HI andHF did
not inhibit the induction of aP2, adiponectin, PPARγ, and STAT5A that
normally accompanies adipogenesis. Both HF doses and 0.5 μM HI
resulted in equivalent adipocyte marker protein levels compared to
the respective vehicle treatment. Additionally, a combined treatmentF 3
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Fig. 1. Hypericin and hyperforin do not inhibit adipogenesis. 3T3-L1 preadipocytes, induced t
DMSO vehicle (V), methanol vehicle (M), 50 μg/ml ﬂower (F) and root (R) extracts of SJW,
following each media change every 48–72 h. Control cells (C) received no treatment. Each p
ing of neutral lipid content was performed 7 days post-MDI. All of the wells shown were stain
of whole cell extracts from cells harvested four days post-MDI. Similar results were obtaineof approximately 0.5 μM HI and HF was also not capable of inhibiting
lipid accumulation or the induction of adipocytemarker protein expres-
sion (data not shown). As a result of its toxicity, no adipocyte marker
protein bands were observed for the 3 μM HI treatment. Based on its
percent composition as described above, the 3 μMdose of HIwas higher
than the calculated concentration of HI in the active SJW extracts. Since
this HI dose was toxic to differentiating 3T3-L1 preadipocytes, we fo-
cused on the 0.5 μMdose of HI and HF for our studies inmature fat cells.
3.2. Effects of SJW extract, HI, and HF on insulin-sensitive glucose uptake
We previously observed that the SJW ﬂower extract induced insulin
resistance in fully differentiated murine 3T3-L1 adipocytes [1]. To ad-
dress the relevance of this observation in human cells, we assessed
the ability of the ﬂower extract to inhibit insulin-stimulated glucose up-
take in mature subcutaneous human adipocytes. As shown in Fig. 2A,
untreated control human adipocytes were not highly responsive to in-
sulin treatment, which resulted in a small, not statistically signiﬁcant
1.5-fold increase in glucose uptake. Nonetheless, compared to theHI Dose 
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o differentiate using the typical MDI cocktail, were treated at the time of induction with
or indicated the doses of hypericin (HI) and hyperforin (HF). The cells were retreated
anel is representative of 3–6 independently performed experiments. A: Oil Red O stain-
ed at the same time with the same Oil Red O working solution. B: Western blot analysis
d at 4 and 7 days post-MDI, and panel B contains a representative subset of these blots.
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Fig. 2. HI and HF do not mediate insulin resistance induced by the SJW ﬂower extract.
A: Mature subcutaneous human adipocytes were serum deprived overnight before per-
forming glucose uptake assays. Prior to insulin administration, the cells were either
untreated or pre-treated with 50 μg/ml SJW-F extract for 18 h. B: Fully differentiated
3T3-L1 adipocytes were serum deprived and pre-treated with DMSO vehicle (V),
0.5 μMHI, and 0.47 μMHFovernight or 50 μg/ml SJW-F for 4 h prior to performing glucose
uptake assays. Similar results were obtained with an overnight treatment of SJW-F. The
glucose uptake values shown represent the mean±SEM of triplicate determinations
from two independent experiments. *pb0.02 (n=3): SJW-F versus CTL (plus insulin);
**pb0.0001 (n=3): SJW-F versus V, HI, and HF (plus insulin).
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these human adipocytes were reduced in the presence of the SJW ﬂow-
er extract. While the decrease in basal glucose uptake observed when
the fat cells were treated with SJW-F was not statistically signiﬁcant,
the reduction of insulin-sensitive glucose uptake in the presence of
SJW-F did reach statistical signiﬁcance (pb0.02) compared to CTL
untreated, insulin-stimulated human adipocytes (Fig. 2A).
Our prior investigations showed that SJW ﬂower extract inhibited
insulin-sensitive glucose uptake in 3T3-L1 adipocytes [1]. Therefore,
we examined the ability of HI or HF to impair the function of fully dif-
ferentiated fat cells by assessing the capacity of these compounds to
modulate insulin-stimulated glucose uptake in murine adipocytes.
As shown in Fig. 2B, vehicle-treated 3T3-L1 adipocytes were highly
responsive to insulin treatment, which resulted in a 9-fold increase
over the basal glucose uptake rate. Compared to the vehicle-treated
cells, neither HI nor HF signiﬁcantly altered basal or insulin-sensitive
rates of glucose uptake. However, SJW ﬂower extract substantially in-
hibits insulin-sensitive glucose uptake.
3.3. Effects of SJW extracts, HI, and HF on IRS-1 tyrosine phosphorylation
To investigate how the SJW ﬂower extract disrupts insulin signal-
ing in fat cells, we examined its ability to inhibit tyrosine phosphory-
lation of IRS-1. IRS-1 is a key protein in insulin signaling, and
inhibition of its expression or tyrosine phosphorylation is often asso-
ciated with insulin resistance [25]. Using a phosphospeciﬁc anti-IRS-1
pY896 antibody, wemonitored the effect of the ﬂower extract on IRS-1phosphorylation at tyrosine896 in mature 3T3-L1 and human adipo-
cytes following administration of an acute dose of insulin. As shown
in Fig. 3, we observed a robust increase in IRS-1 pY896 following insu-
lin stimulation of DMSO vehicle-treated mouse and human adipo-
cytes. However, an overnight pre-treatment of murine and human
fat cells with the ﬂower extract substantially inhibited insulin-
induced IRS-1 tyrosine phosphorylation. Additionally, the SJW ﬂower
extract also blocked IRS-1 phosphorylation in human adipocytes fol-
lowing 30 minute and 6 hour pre-treatments (Fig. 3B).
To complete our evaluation of the capability of HI and/or HF to
mediate the effects of the SJW ﬂower extract on adipocyte function,
we also examined their ability to modulate insulin-stimulated IRS-1
tyrosine phosphorylation in mouse and human adipocytes. As
shown in Fig. 4A, following an overnight pre-treatment of murine
3T3-L1 adipocytes with HF, IRS-1 pY896 was substantially induced
by acute stimulation with insulin. The magnitude of this response
was comparable to that of the untreated control and methanol
vehicle-treated cells. In murine adipocytes, pre-incubation with HI
for 2 h was also unable to signiﬁcantly inhibit IRS-1 pY896 in the pres-
ence of insulin (data not shown). Conversely, using adipocytes from
the same group, we examined the effect of the ﬂower extract as a pos-
itive control, and as shown in Fig. 4A, we observed that it completely
blocked insulin-sensitive phosphorylation of IRS-1 at tyrosine896
without decreasing total IRS-1 protein levels. For the data shown in
Fig. 4A, the cells were pre-treated with HF overnight and with the
SJW ﬂower extract for 2 h. Nevertheless, we observed results compa-
rable to those shown by pre-treating the 3T3-L1 adipocytes for 2 h
with HF (data not shown). Additionally, neither HI nor HF was capa-
ble of inhibiting IRS-1 phosphorylation in fully differentiated human
adipocytes (Fig. 4B). Unlike the data presented from the murine
3T3-L1 adipocytes, we observed IRS-1 pY896 under basal conditions
in the human fat cells, and they were less sensitive to insulin stimula-
tion than the mouse adipocytes (i.e. the induction of IRS-1 pY896 was
less substantial than observed for the 3T3-L1 fat cells). Regardless,
compared to the untreated control and vehicle treatments, IRS-1
pY896 levels were not decreased in the presence of HI or HF. Nonethe-
less, these are the ﬁrst studies to demonstrate that an extract of SJW
can inhibit IRS activation in both mouse and human fat cells.
4. Discussion
Our recently published work [1] demonstrated that extracts of
SJW impair adipogenesis and insulin action in murine fat cells. In
our current studies, we have extended our examination of the effects
of SJW and its known bioactive constituents, hypericin and hyper-
forin, on the development and function of murine adipocytes. More-
over, we have demonstrated that human adipocytes are also sensitive
to the negative effects of SJW. However, these profound effects of SJW
onmouse and human fat cells are notmediated byHI or HF. In response
to insulin, human subcutaneous fat cells do not exhibit a 6–10 fold in-
crease in glucose uptake as has been observed in mouse adipocytes.
Nonetheless, we clearly observed impaired insulin-stimulated glucose
uptake following treatment with the SJW ﬂower extract in human
fat cells. In both murine and human adipocytes, insulin-induced
IRS-1 tyrosine phosphorylation was substantially attenuated. Since
both limited expansion of adipose tissue and impaired insulin signal-
ing in adipocytes have been associated with the development of in-
sulin resistance [10,12], we propose that the results from our in
vitro investigations suggest that SJWusage has the potential to cause in-
sulin resistance in vivo.
Although our studies on SJW are limited to in vitro observations,
there is some other data to support a role of SJW in insulin resistance.
Mukerjee and colleagues recently demonstrated that an endogenous
protein puriﬁed from SJW can increase MCP-1 expression via modula-
tion of its promoter [19]. Monocyte chemoattractant protein 1 (MCP-
1) regulates the migration and inﬁltration of immune cells into various
STAT5A
IRS-1 (pY896)
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Fig. 3. SJW ﬂower extract modulates insulin action via attenuation of IRS-1 tyrosine896 phosphorylation. A: Mature 3T3-L1 adipocytes were serum deprived and pre-treated with
DMSO vehicle (V) or 25 μg/ml SJW ﬂower (SJW-F) extract overnight. Two independently performed experiments with the ﬂower extract are shown, and this experiment was in-
dependently repeated a total of 2 times. B: Fully differentiated subcutaneous human adipocytes were serum deprived and pre-treated with 25 μg/ml SJW-F for the indicated lengths
of time. Cells were then stimulated with insulin prior to preparation of whole cell extracts. Proteins from the whole cell extracts were resolved and immunoblotted. For each treat-
ment and/or time point in B, data from two separate wells treated with insulin are shown. STAT5A levels are not altered by acute insulin stimulation, and its expression was ex-
amined as a loading control.
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it is well known that a considerable increase inmacrophage-derived in-
ﬂammatory mediators accompanies obesity and T2DM [8]. Moreover,
MCP-1 has been shown to enhance the inﬁltration of macrophages
into adipose tissue and contribute to insulin resistance [13]. Since SJW
has been shown to increase MCP-1 expression [19], it is reasonable to
hypothesize that this popular botanical may also be capable of inducing
insulin resistance in vivo, perhaps via induction of MCP-1.
To date, several bioactive substances have been identiﬁed in SJW.
The greatest interest has focused on the characterization of hypericin
and hyperforin. Not only are these organic compounds associated
with the antidepressant effects of SJW, but they also have been stud-
ied as antiviral, antimicrobial, and anticarcinogenic agents [reviewed
in [17,24]]. Of note, there is a substantial body of literature indicating
that SJW interferes with the action of numerous drugs [reviewed in
[15]]. The ability of SJW to lower the circulating concentrations and
pharmacological efﬁcacy of a number of drugs and oral contraceptives
[7] is largely attributed to hyperforin. HF is a psychoactive constituent
of SJW that potently activates the pregnane X receptor [18], which is
known to turn on various sets of genes that are involved in the me-
tabolism and excretion of drugs [9]. Since hyperforin and hypericin
are considered the primary bioactive ingredients of SJW, the stan-
dardization of SJW extracts currently is based on the content of
both of these phytochemicals; HI content is standardized to 0.3%
and HF content to 3%. Although SJW extracts prevent fat cell differen-
tiation, our studies demonstrate that neither HI nor HF was capable of
inhibiting adipogenesis. Moreover, the ability of SJW to modulate
insulin-sensitive glucose uptake and IRS-1 phosphorylation was not
mediated by HI or HF.
The concentration of HF utilized in our adipogenesis and insulin sen-
sitivity assays was limited by the concentration of the stock solution as
indicated in Section 3.1. The highest HF concentration tested in ourexperiments was 0.47 μM. However, according to the calculations pre-
sented in Section 3.1, the concentration of HFwithin our active SJW ex-
tracts may have been 6-fold higher. Therefore, a plausible explanation
for the lack of effect of HF on adipogenesis may be the use of a sub-
efﬁcacious dose. Conversely, in our insulin-responsive glucose uptake
assay, the effective dose of SJW was lower (3 μg/ml) [1] and corre-
sponds to a maximal HF concentration of 0.28 μM, which is 1.7-fold
lower than the HF dose used in our experiments. Yet, HF was not capa-
ble of inhibiting insulin-sensitive glucose uptake in these studies. Taken
together, these data suggest that neither HI nor HF would elicit the
same potentially harmful metabolic side effects that we propose may
be associated with SJW ﬂower and leaf extracts as a result of their neg-
ative effects on adipocyte development and function.
SJW is comprised of many other bioactive compounds of which ap-
proximately 50–70% have been identiﬁed; these known phytochemi-
cals belong to a variety of chemical classiﬁcations [5]. In addition to HI
and HF, which represent napthodianthrones and phloroglucinols, SJW
is known to contain numerous ﬂavonoids, biﬂavonoids, and phenolic
acids [2]. In this study, we have demonstrated that HI and HF are not ca-
pable of mediating the inhibitory effects of SJW in adipocytes. Further
studies are necessary to identify the component(s) that are responsible
for mediating the ability of SJW extracts to inhibit adipogenesis and in-
duce insulin resistance in fat cells.
4.1. Concluding remarks
In summary, our data indicate that human fat cells, like murine
adipocytes, are highly sensitive to SJW and that this botanical results
in a potent inhibition of IRS-1 tyrosine phosphorylation. In these
novel studies, we demonstrated that the anti-adipogenic effects of
SJW are not mediated by HI and/or HF. Moreover, HI and HF are not
responsible for the ability of SJW to inhibit insulin action in murine
SJW -F
Insulin
10nM, 2min- +      - +      - +        
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Fig. 4.HI and HF do not block IRS-1 tyrosine896 phosphorylation in mature 3T3-L1 or subcutaneous human adipocytes. A: Mature 3T3-L1 adipocytes were serum deprived overnight.
Cells were pre-treated with methanol vehicle (V) and 0.47 μM HF overnight, or with DMSO vehicle and 50 μg/ml SJW ﬂower (SJW-F) extract for 2 h. B: Fully differentiated subcu-
taneous human adipocytes were serum deprived overnight and then pre-treated with DMSO vehicle (V), 0.5 μMHI, methanol vehicle (M), or 0.47 μMHF for 2 h. For each antibody,
the results shown within the rectangle are from the same exposure of the same blot. Control cells (CTL) were untreated. Cells were stimulated with insulin prior to preparation of
whole cell extracts. Proteins from the whole cell extracts were resolved and immunoblotted. STAT5A expression was probed as a loading control. Each panel is representative of an
experiment independently repeated two times.
562 A.J. Richard et al. / Biochimica et Biophysica Acta 1822 (2012) 557–563or human adipocytes. Obesity and diabetes are world-wide epi-
demics, and SJW is a ubiquitous, commercially available herbal reme-
dy that is consumed by millions of people globally as an over-the-
counter treatment for mild depression. We hypothesize that the use
of SJW could have additional health risks besides reducing drug effec-
tiveness. Overall, our studies suggest that SJW may have a negative
impact on adipocyte-related diseases by limiting differentiation of
preadipocytes and signiﬁcantly inducing insulin resistance in mature
fat cells.
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